220 related articles for article (PubMed ID: 26513236)
1. Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects.
Cenderello G; De Maria A
Expert Rev Anti Infect Ther; 2016; 14(1):29-40. PubMed ID: 26513236
[TBL] [Abstract][Full Text] [Related]
2. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
3. Recent trends in early stage response to combination antiretroviral therapy in Australia.
McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG;
Antivir Ther; 2015; 20(2):131-9. PubMed ID: 24704818
[TBL] [Abstract][Full Text] [Related]
4. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
Aiuti F; Mezzaroma I
AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
[TBL] [Abstract][Full Text] [Related]
5. Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.
Kasahara TM; Hygino J; Andrade RM; Monteiro C; Sacramento PM; Andrade AF; Bento CA
Hum Immunol; 2015 Oct; 76(10):701-10. PubMed ID: 26429325
[TBL] [Abstract][Full Text] [Related]
6. Discordant immunological and virological responses to antiretroviral therapy.
Schechter M; Tuboi SH
J Antimicrob Chemother; 2006 Sep; 58(3):506-10. PubMed ID: 16854959
[TBL] [Abstract][Full Text] [Related]
7. Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.
Guihot A; Tubiana R; Breton G; Marcelin AG; Samri A; Assoumou L; Goncalves E; Bricaire F; Costagliola D; Calvez V; Rouzioux C; Autran B; Katlama C; Carcelain G; ;
AIDS; 2010 Feb; 24(4):614-7. PubMed ID: 19952710
[TBL] [Abstract][Full Text] [Related]
8. Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study.
Kayigamba FR; Franke MF; Bakker MI; Rodriguez CA; Bagiruwigize E; Wit FW; Rich ML; Schim van der Loeff MF
PLoS One; 2016; 11(7):e0159446. PubMed ID: 27438000
[TBL] [Abstract][Full Text] [Related]
9. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
[TBL] [Abstract][Full Text] [Related]
10. Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.
Lisco A; Wong CS; Lage SL; Levy I; Brophy J; Lennox J; Manion M; Anderson MV; Mejia Y; Grivas C; Mystakelis H; Burbelo PD; Perez-Diez A; Rupert A; Martens CA; Anzick SL; Morse C; Chan S; Deleage C; Sereti I
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996137
[TBL] [Abstract][Full Text] [Related]
11. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
[No Abstract] [Full Text] [Related]
12. Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART).
Torti C; Cologni G; Uccelli MC; Quiros-Roldan E; Imberti L; Airó P; Pirovano S; Patroni A; Tirelli V; Carosi G
Viral Immunol; 2004; 17(2):279-86. PubMed ID: 15279705
[TBL] [Abstract][Full Text] [Related]
13. Viral Decay Dynamics and Mathematical Modeling of Treatment Response: Evidence of Lower in vivo Fitness of HIV-1 Subtype C.
Shet A; Nagaraja P; Dixit NM
J Acquir Immune Defic Syndr; 2016 Nov; 73(3):245-251. PubMed ID: 27273158
[TBL] [Abstract][Full Text] [Related]
14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
15. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
17. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
[TBL] [Abstract][Full Text] [Related]
18. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
19. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
Gezie LD
BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
[TBL] [Abstract][Full Text] [Related]
20. Plasticity of the Immune System in Children Following Treatment Interruption in HIV-1 Infection.
Sandgaard KS; Margetts B; Attenborough T; Gkouleli T; Adams S; Holm M; Gibb D; Gibbons D; Giaquinto C; De Rossi A; Bamford A; Palma P; Chain B; Gkazi AS; Klein N
Front Immunol; 2021; 12():643189. PubMed ID: 34475868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
